- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Fulvestrant Placebo
Total 54108 results
-
Genzyme, a Sanofi CompanyCompletedNon-Hodgkin's Lymphoma | Autologous Transplantation
-
Veru Inc.TerminatedMetastatic Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHormone Receptor Positive Advanced Breast CancerChina
-
AstraZenecaCompletedProgression-free SurvivalKorea, Republic of
-
Ahon Pharmaceutical Co., Ltd.Affiliated Hospital of Hebei University; The First Hospital of Jilin University and other collaboratorsRecruiting
-
SanofiRegeneron PharmaceuticalsCompletedNasal PolypsSpain, Belgium, United States, Sweden
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
PfizerCompletedBreast NeoplasmsQatar, United Arab Emirates, Saudi Arabia
-
Cedars-Sinai Medical CenterUnknown
-
Li HuipingNot yet recruiting
-
Jiangsu HengRui Medicine Co., Ltd.Completed
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHER2 Low Advanced or Metastatic Breast Cancer
-
Tvardi Therapeutics, IncorporatedActive, not recruiting
-
PfizerAstraZenecaCompletedMetastatic Breast CancerKorea, Republic of, United States, Canada, United Kingdom, Australia, Taiwan, Netherlands, Italy, Japan, Belgium, Ireland, Ukraine, Portugal, Germany, Romania, Russian Federation, Turkey
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
The Netherlands Cancer InstituteAstraZenecaSuspendedBreast CancerNetherlands
-
National University Hospital, SingaporeUnknown
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
Samsung Medical CenterAsan Medical Center; Seoul National University Hospital; Ulsan University Hospital and other collaboratorsUnknownMetastatic Breast Cancer | Estrogen Receptor Positive Tumor | Breast Cancer Nos PremenopausalKorea, Republic of
-
University of ArkansasOSI PharmaceuticalsTerminated
-
Syndax PharmaceuticalsWithdrawn
-
Consorzio OncotechUnknown
-
Royal Marsden NHS Foundation TrustPfizer; Hoffmann-La RocheRecruitingAdvanced Breast Cancer | Metastatic Breast Cancer | ER+ Breast CancerUnited Kingdom
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruiting
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
Seagen Inc.Active, not recruitingUrologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Carcinoma, Non-Small-Cell Lung | Biliary Tract Neoplasms | HER2 Mutations Breast NeoplasmsUnited States, United Kingdom, Spain, Korea, Republic of, Italy, Belgium, Germany, Japan, Netherlands, Poland
-
Georgetown UniversityUniversity of Chicago; Thomas Jefferson UniversityCompletedHormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Canadian Cancer Trials GroupHoffmann-La RocheActive, not recruiting
-
Kyowa Kirin Co., Ltd.CompletedMultiple Myeloma and Malignant LymphomaJapan
-
Ege UniversityCompletedSleep | AnxietyTurkey
-
Avenzo Therapeutics, Inc.Recruiting
-
Melissa K AccordinoNovartis PharmaceuticalsActive, not recruitingMetastatic Breast Cancer | Breast CarcinomaUnited States
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
Ramón Óscar González-Ramella, Ph.DHospital Civil Juan I. Menchaca; Instituto de Investigacion en Cancer de la... and other collaboratorsUnknownAcute Lymphoblastic LeukemiaMexico
-
The Affiliated Hospital of Qingdao UniversityNot yet recruitingNeoplasms | Breast Cancer | Breast DiseasesChina
-
PfizerRecruitingBreast Cancer | Solid TumorsChina, United States, Mexico, Bulgaria, Spain, Brazil, Czechia, Argentina, South Africa
-
UNICANCERPfizerActive, not recruitingMetastatic Breast CancerFrance
-
Washington University School of MedicineCompleted
-
Dr. Reddy's Laboratories SASRecruitingBreast Neoplasm FemaleColombia
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsCompletedBreast CancerUnited States
-
Orphan AustraliaCompleted
-
Eli Lilly and CompanyActive, not recruitingBreast CancerChina, India, South Africa, Brazil
-
PrECOG, LLC.NovartisCompletedMetastatic Breast CancerUnited States
-
Mayo ClinicCompleted
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompleted
-
AstraZenecaCompletedEndometrial CarcinomaGermany
-
Nowarta Biopharma IncCompletedPlantar WartsUnited States
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
Sermonix Pharmaceuticals Inc.Linical Accelovance GroupActive, not recruitingLocally Advanced or Metastatic Breast CancerUnited States, Canada, Israel
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast CancerItaly